Skip to main content
. 2024 Mar 7;90(4):101411. doi: 10.1016/j.bjorl.2024.101411

Figure 1.

Figure 1

The expression of EPHX4 in laryngeal cancer and its clinical significance. (A) The significant upregulation of EPHX4 was observed in laryngeal cancer. (B) Survival assays based on TCGA datasets. A poor prognosis was observed in laryngeal cancer by TCGA datasets with high EPHX4 expression.